Northstar Financial Companies’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$706K Buy
2,807
+26
+0.9% +$5.59K 0.48% 55
2026
Q1
$605K Sell
2,781
-106
-4% -$23.5K 0.48% 52
2025
Q4
$660K Buy
2,887
+32
+1% +$7.29K 0.53% 52
2025
Q3
$661K Buy
2,855
+1
+0% +$204 0.61% 38
2025
Q2
$530K Sell
2,854
-3,891
-58% -$723K 0.55% 49
2025
Q1
$1.41M Sell
6,745
-115
-2% -$22.4K 1.53% 13
2024
Q4
$1.22M Buy
+6,860
New +$1.26M 1.15% 16

Other funds holding ABBV

Northstar Financial Companies's ABBV Position: Q2 2026 in Review

Northstar Financial Companies increased its AbbVie (ABBV) stake by 0.93% in Q2 2026, buying an estimated $5.59K and bringing the position to 2,807 shares worth $706K. The position accounts for 0.48% of the portfolio, ranked #55.

Northstar Financial Companies first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.41M in Q1 2025. 2,700 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Northstar Financial Companies held 2,807 shares of AbbVie worth $706K as of Q2 2026.
  • Northstar Financial Companies bought 26 AbbVie shares in Q2 2026, an estimated $5.59K.
  • AbbVie made up 0.48% of Northstar Financial Companies's portfolio in Q2 2026, its #55 holding.
  • Northstar Financial Companies first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • Northstar Financial Companies's AbbVie position peaked at $1.41M in Q1 2025.
  • 2,700 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Northstar Financial Companies's 13F filing for Q2 2026, filed 6 Aug 2026.